{
    "title": "\u00a319m blow as Celltech drops drug",
    "url": "https://www.dailymail.co.uk/money/news/article-1521525/16319m-blow-as-Celltech-drops-drug.html",
    "date": "2003-08-18",
    "keywords": [
        "disease",
        "drug",
        "treatment",
        "ando",
        "group",
        "celltech",
        "today",
        "crohns",
        "cdp",
        "arthritis",
        "inflammation",
        "business",
        "development",
        "takeover",
        "year",
        "johnson",
        "blow",
        "malcolm",
        "gmt",
        "view",
        "biotech",
        "rise",
        "portfolio",
        "chief",
        "executive",
        "goran",
        "growth",
        "charge",
        "appointment",
        "april",
        "place",
        "peter",
        "fellner",
        "chairman",
        "turnover",
        "june",
        "facility",
        "ana",
        "california",
        "research",
        "programme",
        "series",
        "integration",
        "end",
        "bank",
        "couple",
        "market",
        "humicade",
        "humiliation",
        "partner",
        "merck",
        "asthma",
        "patient",
        "colitis",
        "followup",
        "part",
        "pfizer",
        "fruition",
        "rheumatoid",
        "sale",
        "ftse",
        "dozen",
        "zavesca",
        "approval",
        "food",
        "administration",
        "addition",
        "europe",
        "israel",
        "gaucher",
        "mylotarg"
    ],
    "category": [
        "money",
        "news"
    ]
}